IDH1 and acute myeloid leukemia: IDHs are important regulators of the normal citrate metabolism and IDH1/2 genes are mutated in 15–33% of AML cases, causing a shift from normal a-ketoglutarate production to generation of the oncometabolite 2-hydroxyglutarate8.